Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.32M | -2.18M | -2.06M | -2.18M | -2.29M |
| Total Depreciation and Amortization | 89.80K | 92.50K | 95.60K | 96.90K | 97.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.59M | 1.79M | 36.60K | 120.10K | 214.80K |
| Change in Net Operating Assets | -695.50K | -695.50K | -695.50K | -479.70K | -254.80K |
| Cash from Operations | 665.60K | -993.00K | -2.62M | -2.44M | -2.23M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.40K | -10.40K | -10.40K | -5.30K | -- |
| Cash from Investing | -10.40K | -10.40K | -10.40K | -5.30K | -- |
| Total Debt Issued | 931.60K | 931.60K | 931.60K | 465.80K | -- |
| Total Debt Repaid | -1.01M | -544.40K | -77.00K | -75.40K | -73.80K |
| Issuance of Common Stock | -- | -- | -- | 3.03M | 6.06M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -303.10K | -606.20K |
| Cash from Financing | -27.00K | 272.10K | 564.80K | 2.04M | 3.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 628.30K | -731.20K | -2.07M | -404.90K | 1.28M |